Canada Pension Plan Investment Board
RXRX icon

Canada Pension Plan Investment Board’s Recursion Pharmaceuticals RXRX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-98,400
Closed -$402K – 1969
2025
Q4 		$402K Buy
+98,400
New +$487K ﹤0.01% 1390

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Canada Pension Plan Investment Board's RXRX Position: Q1 2026 in Review

Canada Pension Plan Investment Board sold out of Recursion Pharmaceuticals (RXRX) in Q1 2026, closing a stake of 98,400 shares — an estimated $402K sold.

Canada Pension Plan Investment Board first reported a position in RXRX in Q4 2025 and held it in 1 quarter. The position peaked at $402K in Q4 2025. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Canada Pension Plan Investment Board reported no remaining Recursion Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 98,400 Recursion Pharmaceuticals shares in Q1 2026, an estimated $402K.
  • Canada Pension Plan Investment Board first reported a position in Recursion Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • Canada Pension Plan Investment Board's Recursion Pharmaceuticals position peaked at $402K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.